Gonadorelin is the synthetic form of the hypothalamic hormone GnRH — the master regulator of reproductive hormone signaling. It sits at the top of the hypothalamic-pituitary-gonadal axis and controls the release of LH and FSH.
Research Applications
HPG axis maintenance, fertility research, pituitary function diagnostics, LH/FSH stimulation, and testosterone production support research.
Dosage Information (Research Use)
Research protocols: 100-250 mcg subcutaneously, 2-3 times weekly. Pulsatile dosing preferred. Research use only.
Reconstitution & Handling
Standard BAC water reconstitution.
Half-Life & Pharmacokinetics
Approximately 2-4 minutes. Very short, mimicking the natural pulsatile GnRH release pattern.
Reported Observations in Literature
Generally well-tolerated. Headache, injection site reactions. Continuous (non-pulsatile) administration causes paradoxical suppression of LH/FSH.
Key Research References
- Conn PM, Crowley WF. “Gonadotropin-releasing hormone and its analogs.” Annu Rev Med. 1994